tiprankstipranks
Achieve Life Sciences Inc (ACHV)
NASDAQ:ACHV

Achieve Life Sciences Stock Analysis & Ratings

ACHV Stock Chart & Stats

Day’s Range$6.77 - $7
52-Week Range$5.62 - $10.40
Previous Close$6.83
Volume5.98K
Average Volume (3M)73.76K
Market Cap$66.03M
P/E Ratio-1.6
Beta1.14
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score9
EPS (TTM)-4.30


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ACHV FAQ

What was Achieve Life Sciences’s price range in the past 12 months?
Achieve Life Sciences lowest stock price was $5.62 and its highest was $10.40 in the past 12 months.
    What is Achieve Life Sciences’s market cap?
    Achieve Life Sciences’s market cap is $66.03M.
      What is Achieve Life Sciences’s price target?
      The average price target for Achieve Life Sciences is $26.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $35.00 ,the lowest forecast is $21.00. The average price target represents 291.06% Increase from the current price of $6.82.
        What do analysts say about Achieve Life Sciences?
        Achieve Life Sciences’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is Achieve Life Sciences’s upcoming earnings report date?
          Achieve Life Sciences’s upcoming earnings report date is Aug 10, 2022 which is in 84 days.
            How were Achieve Life Sciences’s earnings last quarter?
            Achieve Life Sciences released its earnings results on May 12, 2022. The company reported -$0.8 earnings per share for the quarter, beating the consensus estimate of -$0.802 by $0.002.
              Is Achieve Life Sciences overvalued?
              According to Wall Street analysts Achieve Life Sciences’s price is currently Undervalued.
                Does Achieve Life Sciences pay dividends?
                Achieve Life Sciences does not currently pay dividends.
                What is Achieve Life Sciences’s EPS estimate?
                Achieve Life Sciences’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Achieve Life Sciences have?
                Achieve Life Sciences has 9,680,000 shares outstanding.
                  What happened to Achieve Life Sciences’s price movement after its last earnings report?
                  Achieve Life Sciences reported an EPS of -$0.8 in its last earnings report, beating expectations of -$0.802. Following the earnings report the stock price went up 3.912%.
                    Which hedge fund is a major shareholder of Achieve Life Sciences?
                    Currently, no hedge funds are holding shares in ACHV

                    ---

                    Achieve Life Sciences Stock Analysis

                    Smart Score
                    9
                    Outperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    Price Target
                    $26.67
                    ▲(291.06% Upside)
                    Strong Buy
                    The Achieve Life Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Achieve Life Sciences Inc

                    Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products, cytisine, is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Teva Pharmaceutical
                    Ionis Pharmaceuticals
                    RedHill Biopharma

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis